This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting. We do not share any your subscription information with third parties. It is used solely to send you notifications about site content occasionally.

Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Dear Readers,

Welcome to the March 2022 TotalHealth Magazine Special Report by Charles K. Bens, PhD.

Abstract: Cardiovascular disease is the number one cause of death in North America. It’s also a greater risk these days because many people are suffering heart issues as a result of COVID-19 infection, as well as the vaccinations. Conventional medical has traditionally treated heart disease, such as a heart attack, stroke or a diagnosis of arteriosclerosis with medications or surgery. The COVID-19 virus has expanded the usual causal factors of this illness, like poor diet, smoking and lack of exercise, to include cellular damage caused by the coronavirus’ invasion of cells via the ACE-2 receptors. These receptors are found in high numbers on highly active cells like those present in the heart and the circulatory system. Conventional treatments have been somewhat successful in managing these conditions, but new scientific evidence is pointing to the capability of damaged cells in the cardiovascular system to be repaired, potentially leading to better and longer survival outcomes. New diagnostic tools are able to find cellular damage five to ten years before cardiovascular events occurs. Advance dietary approaches and nutraceuticals have also shown promise in the repair of cellular damage both from traditional causes, as well as from damage related to COVID-19 infections and injections. This presents an ideal opportunity for doctors, scientists and those responsible for healthcare decision-making to encourage the use of this new prevention and treatment protocol. Implementing this strategy should include well-designed, long-term studies that validate the proof of concept outlined in this article.

Every year over 800,000 people in the United States have a heart attack and over 90% of them survive, at least initially.1 The causes are very well known, but are worth repeating.

  • Eating an unhealthy diet
  • Being overweight or obese
  • Excessive alcohol use
  • Having diabetes (many people are unaware they are prediabetic or diabetic)
  • Having high blood pressure (many people are unaware they have high blood pressure)
  • Being chronically stressed
  • Not getting enough physical activity
  • Low levels of magnesium (as measured by the RBC magnesium test)
  • High ratio of LDL to HDL cholesterol (is a contributing factor, but not a direct cause)
  • Consuming tobacco in any way

Click here to read the full March 2022 Special Report issue or to download a printable PDF version.

  • Standard of care vs. optimized care
  • Repairing damaged heart tissues
  • Understanding the cellular repair process
  • The cell replacement process
  • The primary DNA cellular repair nutraceuticals
  • The secondary DNA damage repair nutraceuticals
  • Nutraceutical honor role
  • Who can benefit from this program?
  • How to measure the early stages of cellular deterioration
  • Optimizing the cellular repair and replacement process
  • Understanding and supporting the repair process elements
  • Emerging cardiovascular damage reduction strategies
  • Conclusion and final thoughts
  • The Six Stages of Cellular Deterioration
  • References
  • Endorsements

Click here to read the full March 2022 Special Report issue or to download a printable PDF version.

Total Health